Luma Therapeutics and the illuvinate™ system were featured on FierceBiotech after the Dec. 5, 2018 launch of the innovative light-based therapy for the treatment of plaque psoriasis.

“The smartphone-controlled device combines narrowband ultraviolet light with a hydrogel that helps keep moisture in the skin during use. The UVB light reduces psoriasis symptoms by preventing overactive immune cells from releasing growth factors into the skin.”

Visit their website to view the full article.

About FierceBiotech

FierceBiotech provides end-to-end coverage of biotech and medtech from pre-clinical science through clinical testing and regulatory approval.